FDA clears Atrium Therapeutics 37-patient clinical trial
Atrium Therapeutics (NASDAQ:RNA) received FDA clearance for its Investigational New Drug application to begin a 37-participant Phase 1/2 clinical trial.

Crypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.
Atrium Therapeutics (NASDAQ:RNA) received FDA clearance for its Investigational New Drug application to begin a 37-participant Phase 1/2 clinical trial.
Escalating tensions in the Strait of Hormuz are threatening not only oil supplies but also critical sulphur shipments, with a partial closure of the maritime chokepoint disrupting significant volumes of seaborne sulphur trade, according to a Bloomberg Markets report.
Wells Fargo (NYSE:WFC) reported a 17% increase in net income to $6.41 billion for the second quarter.
SemiLEDs (NASDAQ:LEDS) reported fiscal Q3 2026 revenue of $9.1 million and net income of $1.5 million, reversing the previous quarter’s loss.
SILITH Technology and United Microelectronics (NYSE:UMC) delivered the first mass-produced photonic integrated circuit wafers from UMC’s Singapore fab for SILITH’s 1.6T silicon photonics platform.
The temporary suspension of Telegram's t.me links disrupted access to cryptocurrency wallets, bots and community channels.
HeraMED (ASX:HMD) completed its six-month maternity pilot with US-based Lee Health across 44 patients.
Immutep (ASX:IMM) has secured United States patent number 12,673,088 for its cancer immunotherapy combination treatments.
Webull received a Markets in Crypto-Assets (MiCA) licence to launch cryptocurrency services across the European Economic Area.
Ethereum (CRYPTO:ETH) fell below US$1,800 after renewed conflict between the United States and Iran increased pressure on global financial markets.